Skip to main content

Table 7 Six month amputation rates by Rutherford class

From: The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design

Rest pain/R4

N

Amp N

Amp %

Brass 2006

88

3

3.4%

Klomp 1999

19

3

15.8%

Benoit 2011

7

0

0.0%

 

114

6

5.3%

Tissue Loss/R5

N

Amp N

Amp %

Brass 2006

102

12

11.8%

Klomp 1999

41

16

39.0%

Benoit 2011

7

5

71.4%

 

150

33

22.0%